Astellas Submits New Drug Application for Zolbetuximab in Japan

Ministry of Health, Labour and Welfare to evaluate zolbetuximab as treatment option for patients with advanced gastric and gastroesophageal cancers TOKYO, June 9, 2023 -- (Healthcare Sales & Marketing Network) -- Astellas Pharma Inc. (TSE: 4503, Presid... Biopharmaceuticals, Oncology, Regulatory Astellas Pharma, zolbetuximab, gastric cancer, gastroesophageal cancer
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news